Allergan shares spike on M&A rumours
This article was originally published in Scrip
Executive Summary
Allergan's share price has surged on speculation that it is to be merged or acquired. Shares in the US company closed at $48.95 yesterday, 13% up on the day before and their highest value since the beginning of October.